ELAINE L. ALEXANDER, M.D., Ph.D.; STEVEN S. BEALL, M.D.; BARRY GORDON, M.D., Ph.D.; OLA A. SELNES, Ph.D.; GEORGE D. YANNAKAKIS, M.D.; NICHOLAS PATRONAS, M.D.; THOMAS T. PROVOST, M.D.; HENRY F. McFARLAND, M.D.
Thirty-eight patients with the primary Sjögren syndrome, 16 with active neuropsychiatrie manifestations and 22 without clinical evidence of central nervous system involvement had magnetic resonance (MR) imaging. Eight patients had focal neurologic deficits (6 of these also had psychiatric or cognitive dysfunction), and 8 had psychiatric or cognitive abnormalities alone. Magnetic resonance imaging showed abnormal results in 12 of 16 (75%; 95% Cl, 48 to 93) patients with active central nervous system disease (67 focal lesions predominantly within the subcortical and periventricular white matter), and in 2 of 22 (9%; 95% Cl, 1 to 29) patients without clinical evidence of central nervous system disease (P < 0.0001). Seven of eight patients with focal neurologic deficits and 5 of 8 patients with psychiatric or cognitive dysfunction alone had abnormal results on MR imaging. Magnetic resonance imaging was more sensitive in the subgroup with focal deficits, (sensitivity, 88%; 95% Cl, 44 to 97) than computerized axial tomography or cerebral angiography. Magnetic resonance imaging detects focal cerebral lesions in patients with the Sjögren syndrome and central nervous system involvement, including patients with psychiatric and cognitive dysfunction alone.
ALEXANDER EL, BEALL SS, GORDON B, et al. Magnetic Resonance Imaging of Cerebral Lesions in Patients with the Sjögren Syndrome. Ann Intern Med. 1988;108:815–823. doi: 10.7326/0003-4819-108-6-815
Download citation file:
Published: Ann Intern Med. 1988;108(6):815-823.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use